Epiphora
18
1
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
2 terminated out of 18 trials
81.8%
-4.7% vs benchmark
22%
4 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum Stenosis
Examination of Lacrimal Sac and Nasal Mucosa Preparations Taken in Dacryocystorhinostomy Surgery of Patients With Nasolacrimal Duct Obstruction and Comparison of Clinical Groups With Each Other
Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain?
Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?
Bupivacaine Epiphora Trial
Comparative Study Between Wide and Narrow Fenstrum Endoscopic DCR
Placement of Three Interrupted Sutures After Triangular Three-snip Punctoplasty
Topical Cyclosporine-A for Management of Epiphora
Management of Lower Punctal Stenosis.
Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
Lacrimal Drainage Resistance Study
Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora
Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora
Prevention of Docetaxel Induced Dacryostenosis